TABLE 1
Patient characteristics and perioperative parameters
| All patients (n = 213) | Patients with PUL < 16 mm (n = 175) | Patients with PUL ≥ 16 mm (n = 38) | p‐value | |
|---|---|---|---|---|
| Age, years, median (IQR) | 68 (64–71) | 67 (64–71) | 68 (63.3–70.8) | |
| Body mass index, median (IQR) | 24.0 (22.0–26.0) | 24.0 (22.0–25.9) | 23.9 (22.6–26.2) | 0.63 |
| Preoperative PSA, ng/ml, median (IQR) | 7.03 (5.5–10.0) | 7.06 (5.53–26.0) | 7.02 (5.39–9.10) | 0.2 |
| Post‐operative prostate weight, g, median (IQR) | 34.0 (28.2–43.2) | 36.4 (28.3–43.3) | 32.6 (27.5–43.0) | 0.67 |
| Operative time, minute, median (IQR) | 228 (194–268) | 229 (199–273) | 214 (104–191) | 0.78 |
| Console time, minute, median (IQR) | 176 (143–211) | 184 (149–214) | 159 (105–214) | 0.0028 * |
| Bleeding loss, ml, median (IQR) | 100 (50–250) | 100 (50–250) | 100 (50–308) | 0.0043 * |
| Cavernous nerve sparing (%) | 0.37 | |||
| Bilateral | 23 (10.8) | 19 (10.9) | 4 (10.5) | <0.0001 * |
| Unilateral | 45 (21.1) | 24 (13.7) | 21 (55.3) | |
| No | 145 (68.1) | 132 (75.4) | 13 (34.2) | |
| DVC bunching (%) | ||||
| Yes | 100 (46.9) | 99 (56.6) | 1 (2.6) | <0.0001 * |
| No | 113 (53.1) | 76 (43.4) | 37 (97.4) | |
| Endopelvic fascia sparing (%) | ||||
| Bilateral | 64 (30.0) | 43 (24.6) | 21 (55.3) | <0.0001 * |
| Unilateral | 33 (15.5) | 21 (12) | 12 (31.6) | |
| No | 116 (54.5) | 111 (63.4) | 5 (13.2) | |
| Puboprostatic ligament sparing (%) | ||||
| Bilateral | 27 (12.7) | 25 (14.3) | 19 (50) | <0.0001 * |
| Unilateral | 21 (9.9) | 8 (4.6) | 7 (18.4) | |
| No | 164 (77.0) | 142 (81.1) | 12 (31.6) | |
| Anastomotic failure (%) | ||||
| Yes | 29 (13.6) | 20 (11.4) | 9 (23.7) | 0.794 |
| No | 184 (86.4) | 155 (88.6) | 29 (76.3) | |
| PUL, mm, median (IQR) | 10.7 (5.3–10.7) | 8 (5.3–10.7) | 16 (16–16) | |
Abbreviations: DVC, dorsal vein complex; IQR, interquartile range; PSA, prostate‐specific antigen; PUL, preserved urethral length.
*Statistically significant.